Sai Life Sciences is a fully integrated, science-led contract research, development, and manufacturing organization (CRDMO) focused on small molecule new chemical entities (NCEs). It serves global pharmaceutical and biotechnology companies with customized solutions that accelerate the journey of molecules from discovery to the market for a healthier tomorrow.

The company operates a differentiated global delivery model - with discovery and development laboratories near key innovation hubs in the US and UK, and large-scale R&D and manufacturing facilities in India. This structure allows it to work closely with customers during development while seamlessly transferring technologies for cost-efficient commercial-scale manufacturing in India. Its business development teams, based in the US, UK, Europe, and India, strengthen client engagement and drive long-term partnerships.

Sai Life Sciences, an innovator-focused CRDMO, is the only entity of scale in India to possess both CRO and CDMO capabilities for small molecules. With a unique global delivery model, the company acts as a one-stop solution to accelerate the discovery, development, and commercialization for small molecule new chemical entities (NCE) for innovator pharmaceutical and biotech companies. The Company offers integrated solutions spanning medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms across the globe.

Business area of the company

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms. 

Awards, accreditations and recognitions

• 2020: Awarded the ‘Risk Mitigation Award’ by Institute of Supply Chain Management Pvt. Ltd. (ISCM) at the 2nd IPLA, 2020. 
• 2020: Awarded the ‘Best SRM Initiative of the Year Award’ by Institute of Supply Chain Management Pvt. Ltd at the 2nd IPLA, 2020. 
• 2020: Unit IV Bidar facility was awarded the ‘21st National Award for Excellence in Energy Management 2020’ for recognition as an ‘Energy Efficient Unit’ by the Confederation of Indian Industry at the National Award for Excellence in Energy Management, 2020. 
• 2020: Awarded the ‘Golden Peacock National Quality Award, 2020’. 
• 2020: Awarded a ‘Certificate of Excellence’ for securing a ‘5-Star Rating for Excellence in EHS Practices’ by the Confederation of Indian Industry at the CII-SR-EHS Excellence Awards for the year 2020.
• 2021: Awarded the ‘Excellence in Practice Award for Change Management- A Paradigm Shift in Effective Learning’ by the Association for Talent Development. 
• 2021: Awarded gold in ‘Best Advance in Learning Technology Implementation’ by the Brandon Hall Group at the HCM Excellence Awards, 2021.
• 2021: Awarded the ‘Excellence in Practice Award for Learning Technologies- GURUKUL’ by the Association for Talent Development.
• 2021: Awarded ‘The Resilient Procurement Strategy’ by the Institute of Supply Change Management at the India Procurement Leadership Awards - 2021.
• 2021: Unit IV Bidar facility was awarded the ‘22nd National Award for Excellence in Energy Management 2021’ for recognition as an ‘Energy Efficient Unit’ by the Confederation of Indian Industry at the National Award for Excellence in Energy Management, 2021.
• 2021: Awarded the ‘Golden Peacock National Training Award, 2021’ by the Institute of Directors (IOD) at the Golden Peacock Awards.
• 2022: Sai Life Science R&T Centre Hyderabad received the ‘LEED GOLD Certification’ for fulfilment of the requirements of the LEED Green Building Rating System certification by the U.S. Green Building Council & Green Business Certification Inc. in 2022. 
• 2022: Unit IV Bidar Facility was recognized as the ‘Energy Efficient Unit’ and was awarded the ‘23rd National Award for Excellence in Energy Management 2022’ for recognition as an ‘Energy Efficient Unit’ by the Confederation of Indian Industry at the National Award for Excellence in Energy Management, 2022.
• 2023: Awarded gold in ‘Best Advance in Content Authoring Technology’ by the Brandon Hall Group at the Technology Excellence Awards, 2023. 
• 2023: Unit IV Bidar Facility was awarded the ‘24th National Award for Excellence in Energy Management 2023’ for recognition as an ‘Energy Efficient Unit’ by the Confederation of Indian Industry at the National Award for Excellence in Energy Management, 2023. 
• 2023: Awarded the ‘Excellence in Digitalizing L&D’ by the Indian Society of Training and Development, Hyderabad Chapter at the L&D Award Ceremony, 2023.
• 2025: Sai Life Sciences wins Gold at CII Southern Region Awards.
• 2026: Sai Life Sciences recognized as Best Organization for Women (BOW) 2026 by ET Edge.
• 2026: Sai Life Sciences laboratories achieve Green Lab Certification.

History and milestones

• 1999: Incorporation of the company.
• 2002: Inauguration of its R&D labs in ICICI Knowledge Park, Hyderabad. 
• 2004: Strategic acquisitions of Prasad Drugs Limited, the current Unit III Bolarum Facility.
• 2006: Investment by Advantium LLC in the company to set-up discovery services to expand the company’s business. Acquired Merrifield Pharma Private Limited. 
• 2007: Acquisition of shares of the Company held by Advantium LLC by Sequoia Capital India Investments III.
• 2008: Investment by MPM Investment Mauritius in the company.
• 2014: Acquisition of shares of the Company held by MPM Investment Mauritius and Sequoia Capital India Investment III by Tata Capital Healthcare Fund 1.
• 2016: Acquisition of shares of the Company held by MPM Investment Mauritius by HBM Private Equity India and subscription to shares of the company. 
• 2019: Opened biology facility in Watertown (Greater Boston, MA) U.S.A. 
• 2020: Launched Sai Nxt, an initiative aiming to transform the organization into a new generation CDMO Addition of cellular analysis platforms at its discovery biology facility in Cambridge, Massachusetts, USA. 
• 2021: Opened new 75,000 sq. ft. discovery biology facility at its integrated R&D campus at Unit II Hyderabad Facility. 
• 2022: Inauguration of the first set of new discovery chemistry labs as part of the new integrated discovery block at Unit II Hyderabad Facility. 
• 2022: Announced the launch of BIOVIA Electronic Lab Notebook application. 
• 2023: Inauguration of high potency API manufacturing block at Unit IV Bidar Facility. 
• 2024: Initiated API developability & formulations (D&F) capabilities at Unit II Hyderabad.
• 2024: Listed on the Indian bourses – NSE & BSE.
• 2024: Production block-11 commenced for operations.
• 2025: Certified as a Great Place To Work.
• 2025: Opened dedicated facility for Veterinary APIs (Unit VI) in Bidar, India.
• 2025: Became a signatory to the UN Women’s Empowerment Principles.
• 2025: Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators.
• 2026: Opened first facility (Med Chem Block) at new greenfield R&D campus (Unit VIII) in IKP Hyderabad.
• 2026: Sai Life Sciences becomes first Indian CRDMO with a site powered by 100% renewable energy.